CYNTHIA NGUYEN: Open Payments
NPI 1922775121 · BREA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 42 payments from 11 companies in 2025. Trend: 2023 $212 · 2024 $882 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $269 |
| Janssen Biotech, Inc. | 5 | $230 |
| GENZYME CORPORATION | 5 | $163 |
| Incyte Corporation | 4 | $98 |
| UCB, Inc. | 3 | $81 |
| Amgen Inc. | 3 | $61 |
| Galderma Laboratories, L.P. | 2 | $48 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $22 |
| Krystal Biotech Inc | 1 | $21 |
| Stryker Corporation | 1 | $20 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, OPZELURA, Bimzelx, OTEZLA, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
